SEC 13F Intelligence

Highvista Strategies LLC / CDTX

Highvista Strategies LLC’s Cidara Therapeutics Inc Position

Does Highvista Strategies LLC own Cidara Therapeutics Inc (CDTX)? Not currently — the last reported position was 22.9K shares worth $5M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q4 2025
Shares
22.9K
% of Portfolio
+1.30%
Quarters Held
2
position exited

Position History CDTX

Reported value by quarter
Q3 ’25: $7MQ3 ’25Q4 ’25: $5MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202522.9K$5M+1.30%
Q3 202570.9K$7M+1.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of CDTX.